FDA Inspection 1027964 — Rising Son, Inc

Rising Son, Inc — FEI 3005256354

The FDA completed an inspection of Rising Son, Inc on October 6, 2017 in Anoka, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 6, 2017
Fiscal Year
2018
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Anoka, MN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
127421 CFR 211.68(a)Calibration/Inspection/Checking not done